Universal Health Services, Inc. (NYSE:UHS), with a forward P/E of 6.17x and upside potential of 48.10%, is among the top 10 lowest forward P/E stocks in the S&P 500.
A hospital room with a patient using a medical device to administer insulin.
Universal Health Services, Inc. (NYSE:UHS) has been under sustained pressure, but analysts see the selloff as increasingly disconnected from the company’s underlying setup.
Universal Health Services, Inc. (NYSE:UHS) shares hit a 52-week low of $140.76 on June 3, 2026, extending a nearly 25% decline over the past year as of June 8, 2026. On June 1, 2026, Wells Fargo resumed coverage with an “Equal Weight” rating and a $165 price target. The firm left its 2026 EBITDA estimate unchanged but cut its 2027 EBITDA estimate by 3.6% on lower core growth expectations. Wells Fargo said the below-average valuation is justified by Medicaid DPP exposure and the core growth acceleration required to meet estimates.
UBS took a more constructive view on May 29, 2026, reiterating a “Buy” rating and a $310 price target.
The firm said first-quarter results came in largely in line with expectations, with volume softness attributed primarily to weather. Universal Health Services, Inc. (NYSE:UHS) still targets 2% to 3% volume growth in both its acute care and behavioral segments, though management said results could trend toward the lower end given the first-quarter miss.
On the positive side, Florida DPP approval added an incremental $100 million versus the original guidance. Two items partially offset that gain. A slower profitability ramp at the new Cedar Hill facility in Washington, D.C., presents one headwind. Separately, a San Antonio behavioral facility that produced $23 million in operating profit in 2025 will be unable to bill Medicare and Medicaid for eight months this year, swinging to an operating loss.
Universal Health Services, Inc. (NYSE:UHS) provides hospital and healthcare services through more than 400 acute care hospitals, behavioral health facilities, outpatient centers, and ambulatory care access points across the US, Puerto Rico, and the UK.
While we acknowledge the risk and potential of UHS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than UHS and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. Follow Insider Monkey on Google News.
